Netflix has acquired Ben Affleck’s InterPositive and will fold the startup’s team into the streamer as Affleck joins as a senior advisor. The move signals a creator-first push into production-stage AI tools.

A UC lab has developed a menstrual‑fluid home test that early trials say could cut the typical seven‑year wait for an endometriosis diagnosis to months.

Ohio University researchers report a radiation-free wrist test that measured bone stiffness and identified fracture risk better than standard DXA in a multicenter study. The test could fill a major screening gap if larger trials confirm the findings.

Microsoft’s Digital Crimes Unit helped disrupt Tycoon 2FA, seizing core domains tied to an MFA‑bypass phishing network. Security researchers say phishing‑resistant MFA and hardened email gateways are now essential.

Amazon’s cuts and new research show AI is already changing hiring; Philadelphia workers and training programs are racing to adapt. Local entry-level roles are most exposed.

Cognito Therapeutics raised $105M to push Spectris, its at‑home light‑and‑sound therapy for Alzheimer’s, closer to an FDA filing as pivotal trial data arrive.

Dr. Deborah German, founding dean of UCF’s College of Medicine, is preparing to step down after about 20 years, local reporting shows.

OU College of Pharmacy is building a cyclotron on the OU Health campus to produce PET radiopharmaceuticals in‑state, aiming to cut travel and speed access to advanced imaging and therapies.

JobsOhio and Ohio Life Sciences chose New Albany for a $30M training center to teach cGMP and lab skills. The city is pitching in $5M to help build and operate the facility.

Arizona's utility‑scale battery capacity jumped about 129% in 2025 to roughly 19 GWh as Sun Streams 4, Papago and Scatter Wash came online. The projects aim to shore up summer reliability and bring local jobs.

Apache Junction’s council approved a license deal with Google that clears the way for GFiber to be built in the city. Google says construction is expected later in 2026.

After 15 years, Dr. Kevin Tabb will step down from Beth Israel Lahey Health within a year as the system launches a national search and readies a Dana‑Farber cancer hospital.

Five Boston‑area companies landed on LexisNexis’ Top 100 Global Innovators list — the region’s strongest showing yet across biotech and consumer tech.